- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02714426
A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults (MACS)
A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults (The MACS Study: Mindfulness and Attentional Control in Seniors)
Attentional control, or individuals' ability to choose which stimuli in the environment they attend to and which they ignore, declines with older age. Studies from the past two decades suggest that mindfulness meditative practice, such as a standardized mindfulness based stress reduction programs, may increase the efficiency of attention networks.To date, the majority of studies that have related mindfulness meditation practice to attentional control have been based on retrospective self-reported mindfulness or cross-sectional measurement in experienced meditators. More recent experimental studies using pre-post training designs have shown that meditation-naïve individuals can experience attentional improvement with mindfulness intervention. This study seeks to elucidate the time course and process by which such attentional improvements might be achieved.
This research study investigates change in attentional control as participants progress through an 8-week mindfulness-inspired training (MIT) intervention, and has two specific aims: 1) to determine the time course of change in attentional components such as cognitive control and sustained attention as a consequence of MIT; attention will be measured weekly for 3 weeks before, 3 weeks after, and during 8 weeks of MIT. 2) To investigate the extent to which change in attentional performance is coupled/correlated with markers of emotion regulation, perceived mindfulness, and perceived mind wandering.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a 14-week research study exploring week to week changes in attentional control and selected time-varying covariates. The study will involve comparison of two groups of adults aged 65 and older. Half the participants (n=20) will be randomized to received eight weeks of mindfulness-inspired training, while the other half (n=20) are not.
Groups will be compared in the amount of change experienced in measures of attentional control. In addition, the association between changes in emotion regulation, perceived mindfulness, and perceived mind wandering with changes in attentional control will be examined, as well as whether this association differs between persons who did and did not receive mindfulness-inspired training. Measurement will include both paper-and-pencil and computer-administered tests.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32606
- The Vital Laboratory at the The Village
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Able to provide informed consent and perform cognitive and behavioral (mindfulness) interventions;
- Time and willingness to commit to the completion of this study;
- Ability to read at an 8th grade level based on scores on the Wechsler Test of Adult Reading (WTAR) and reading text at 14 point font
Exclusion Criteria:
- Lack of time and willingness to commit to the completion of this 14-week study
- Less than an 8th grade education
- Having been told by a healthcare provider that they (1) have had a stroke or mini-stroke in the past 12 months, (2) have ever had a traumatic brain injury, (3) have had schizophrenia or psychosis, (4) have problem with alcohol or substance abuse
- extreme difficulty reading ordinary print in a newspaper, or have stopped reading due to poor eyesight.
- extreme difficulty hearing, or being completely unable to hear, ordinary speech in low-noise conditions, even with hearing aid.
- Currently participating in cognitive training or brain training
- Having participated in any cognitive or brain training study within the last 6 months
- Currently participating in yoga or meditation based practices
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Brain Health
In weeks 1 and 14, participants receive: Montreal Cognitive Assessment (MoCA), Wechsler Test of Adult Reading (WTAR), Functional Activities Questionnaire (FAQ), Older Americans Resources and Services (OARS) Complete Activities of Daily Living Scale, The Short Form (36) Health Survey (SF-36), Attention measures (Attention Network Test (ANT); Continuous Performance Test (CPT); Auditory Dual Task (ADT); Mind wandering; Cued Stroop), Positive and Negative Affect Scale (PANAS), Geriatric Depression Scale (GDS), Mindfulness Attention Awareness Scale (MAAS), Five Facet Mindfulness Questionnaire (FFMQ), Emotion Regulation Questionnaire (ERQ), State-Trait Anxiety Inventory (STAI), and Starkstein Apathy Scale (AS).
In weeks 4-11, participants receive the Brain Health control instruction.
|
Eight weekly group brain health sessions lasting 90-120 minutes.
The intervention is psychoeducational, and each week presents information from NIH regarding factors that may promote cognitive health in late life (e.g., sleep, physical activity, social engagement and leisure, cognitive training).
Weekly sessions are supplemented with educational videos and group discussion.
Weekly homework consists of readings about brain health.
Other Names:
|
|
Experimental: Mindfulness-inspired Treatment/Testing
Participants receive all of the same measures as the active comparator "Brain Health" condition in Weeks 1-14.
In weeks 4-11, participants receive Mindfulness Inspired Treatment
|
Eight weekly group MIT sessions lasting 90-120 minutes, along with a ½ day Mindfulness Retreat at the end of the training period, will include 1) psychoeducation, 2) formal exercises in the form of guided practice mentioned above, and 3) thoughtful exploration of ideas and questions.
Formal MIT training will follow 21 guided pre-recorded meditative Moving Picture Experts Group Layer-3 Audio (MP3) tracks from the authors for use in class and at home, promoting both fidelity to the model and uniformity in intervention across training groups.
MIT activities in the protocol include mindful breathing, eating, walking, and various other practices well documented in the literature to promote mindfulness.
Participants will be asked to practice MIT on their own time, and to log this.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements
Time Frame: Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
The Attention Network Task is a computerized test that measures three different components of attention (alerting, orienting, and conflict monitoring).
Score is the computed as the difference between reaction time on correct trials in cued and uncued conditions.
Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse)
|
Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance in Useful Field of View Over 14 Weekly Measurements
Time Frame: Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
The useful field of view task is a computer-administered selective visual attention test that determines the minimum presentation time needed (between 16-500 msec) to correctly make two visual judgments: (a) is a centrally presented line drawing of a car or truck?
and (b) where on the screen is a peripheral car located?
Score is the fastest presentation time at which participants achieve at least 75% accuracy.
Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse)
|
Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
|
Performance in Stroop Interference Over 14 Weekly Measurements
Time Frame: Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
This task set is computerized presents participants with a word (red or green or blue) that may be presented in (a) congruent (same) color as the word itself (e.g., red word is printed in red), or (b) incongruent (word red printed in green or blue).
Participants are cued to either select the word or the color, this varies from trial to trial.
Score is the reaction time difference between correct responses to congruent and incongruent stimuli.
Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse)
|
Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-ratings of Perceived Mind Wandering Over 8 Weekly Measurements
Time Frame: Self-ratings of weeks 4, 5, 6, 7, 8, 9, 10, 11
|
Participants in both arms are asked, at the end of each of their eight intervention sessions, to focus on breathing.
They are interrupted five times during this breathing exercise and asked what proportion of their attention (0-100) was wandering off the breathing task.
Score is the average proportion of self-rated mind-wandering over five probes.
Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse)
|
Self-ratings of weeks 4, 5, 6, 7, 8, 9, 10, 11
|
|
Self-ratings in Anxiety (GAD-7) Questionnaire Over 14 Weekly Measurements
Time Frame: Self-ratings in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
Participants will answer computer 7 administered questions about anxiety in the past week.
Score is a Likert-type scale response from the following scale: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day.
Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse)
|
Self-ratings in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
|
Self-ratings on Cognitive and Affective Mindfulness Scale (CAMSr) Over 14 Weekly Measurements
Time Frame: Self-ratings weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
Cognitive and Affective Mindfulness Scale (CAMSr) will be computer administered.
It is a psychological measurement to explore mindfulness.
Each week ten items are rated on a 4-point Likert-type scale (1=rarely/never, 2=sometimes, 3=often, 4=almost always).
Higher scores indicate greater cognitive and emotional focus.
Scores are the average of the ten items, normalized and converted to T-score (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = better) metric.
|
Self-ratings weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jacqueline E. Maye, MS, University of Florida
- Principal Investigator: Michael Marsiske, PhD, University of Florida
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB02-2016-U-0277-N
- 1F31AG051356-01A1 (U.S. NIH Grant/Contract)
- IRB201800586 (Other Identifier: UF IRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Aging
-
Mentage LLCNot yet recruitingCognitive Change | Aging | Healthy Aging | Health Behavior | Primary Care | Cognitive Wellness | Age-Related Cognitive Change
-
KU LeuvenUniversity Ghent; Research Foundation FlandersCompletedCognitive AgingBelgium
-
Institut National de la Santé Et de la Recherche...Completed
-
University of Illinois at Urbana-ChampaignNational Institute on Aging (NIA)CompletedCognitive AgingUnited States
-
Florida State UniversityCompletedCognitive AgingUnited States
-
University of ExeterCompleted
-
University of CincinnatiU.S. Highbush Blueberry Council; Welch Foods IncorporatedCompleted
-
University of California, San FranciscoNational Institute on Aging (NIA)TerminatedCognitive Change | AgingUnited States
-
Jeanne Townsend, PhDNational Institute on Aging (NIA)Unknown
-
Balikesir UniversityCompletedAging | Cognitive PerformanceTurkey
Clinical Trials on Brain health
-
BaycrestCompletedDementia | Mild Cognitive Impairment | Dementia Prevention | Subjective Cognitive Impairment | Pre-dementiaCanada
-
University Health Network, TorontoCompleted
-
University of California, San FranciscoNational Institute on Aging (NIA); Kaiser PermanenteCompletedDementia | Alzheimer DiseaseUnited States
-
Brigham and Women's HospitalActive, not recruitingMild Cognitive Impairment | Subjective Cognitive Decline | Dementia, Mild | At Risk for Cognitive DeclineUnited States
-
Kaiser PermanenteUniversity of California, San FranciscoActive, not recruitingDementia | Alzheimer DiseaseUnited States
-
University of California, San FranciscoNational Institute on Aging (NIA)CompletedCognitive Impairment | Mild Cognitive Impairment (MCI) | Subjective Cognitive DeclineUnited States
-
Posit Science CorporationYMCA of San FranciscoCompletedDementia | Alzheimer DiseaseUnited States
-
Pennington Biomedical Research CenterCompletedCognitive Dysfunction | AgingUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Baycrest; Alzheimer Society of... and other collaboratorsRecruitingCognitive Change | Mild Cognitive Impairment | Lifestyle Intervention | Dementia Prevention | Subjective Cognitive Impairment | Dementia EducationCanada
-
Massachusetts General HospitalRecruitingHealthy Aging | Mild Cognitive Impairment | Subjective Cognitive Concerns | Mild Behavioral ImpairmentUnited States